Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Humanigen, Inc. - Common Stock (NQ:HGEN)

N/A UNCHANGED
Last Price Updated: 4:00 PM EDT, Jul 25, 2023 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open -
Bid (Size) 0.0350 (142)
Ask (Size) 0.0358 (300)
Prev. Close 0.0361
Today's Range N/A - N/A
52wk Range N/A - N/A
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
HGEN Stock Alert: Why Humanigen Just Filed for Ch. 11 Bankruptcy
Humanigen stock is falling hard on Friday as investors in HGEN sell shares after the company announced a bankruptcy filing. 
Via InvestorPlace
Topics Bankruptcy
Exposures Financial Legal
Humanigen Downfall: FDA Rejection For COVID-19 Drug Triggers Financial Crisis, Bankruptcy
Humanigen, previously linked with disgraced pharmaceutical entrepreneur Martin Shkreli, reported $44.1 million in debt. 
Via Benzinga
Exposures COVID-19 Product Safety

Performance

More News

Read More
Humanigen Announces First Participant Dosed in RATinG Trial of Lenzilumab for Early Treatment of Acute Graft Versus Host Disease Following Allogeneic Stem Cell Transplantation
Via Newsfile
Crude Oil Up 1%; Verizon Earnings Beat Views
Via Benzinga
12 Health Care Stocks Moving In Tuesday's Intraday Session
Via Benzinga
Why Alaska Air Group Shares Are Trading Lower By 9%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
Via Benzinga
Stocks That Hit 52-Week Lows On Tuesday
Via Benzinga
Dow Surges 50 Points; General Electric Profit Tops Expectations
Via Benzinga
Nasdaq Rises 70 Points; General Motors Posts Upbeat Earnings
Via Benzinga
Biogen Layoffs 2023: What to Know About the Latest BIIB Job Cuts
Via InvestorPlace
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
Via Benzinga
Why Is Bellerophon Therapeutics (BLPH) Stock Down 34% Today?
Via InvestorPlace
Why Is Humanigen (HGEN) Stock Down 72% Today?
Via InvestorPlace
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
Via InvestorPlace
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
12 Health Care Stocks Moving In Friday's Pre-Market Session
Via Benzinga
Why Squarespace Shares Are Trading Higher By Around 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
Via Benzinga
Why Clene Shares Are Trading Lower By 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Humanigen Presents Promising New Hematologic Data from PREACH-M Trial for Chronic Myelomonocytic Leukemia Treatment at the 2023 European Hematology Association Congress
Via Newsfile
Humanigen - Lenzilumab Being Studied as a Potential First Treatment in Thirty Years with a Novel Mechanism of Action for Chronic Myelomonocytic Leukemia (CMML), an Orphan Form of Leukemia
Via Newsfile
Why Eastside Distilling Shares Are Trading Lower By Over 25%; Here Are 20 Stocks Moving Premarket
Via Benzinga
12 Health Care Stocks Moving In Monday's After-Market Session
Via Benzinga
Why Sabre Are Trading Lower By 19%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
Via Benzinga
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Via Benzinga
Why TripAdvisor Shares Are Trading Higher By 10%; Here Are 20 Stocks Moving Premarket
Via Benzinga

Frequently Asked Questions

Is Humanigen, Inc. - Common Stock publicly traded?
Yes, Humanigen, Inc. - Common Stock is publicly traded.
What exchange does Humanigen, Inc. - Common Stock trade on?
Humanigen, Inc. - Common Stock trades on the Nasdaq Stock Market
What is the ticker symbol for Humanigen, Inc. - Common Stock?
The ticker symbol for Humanigen, Inc. - Common Stock is HGEN on the Nasdaq Stock Market
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.